Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00883610 · ClinicalTrials.gov registry record
Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber Pacemakers
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 12
- Enrollment target
NCT00883610 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 12 participants.
The verdict
NCT00883610 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to learn what effect rapid atrial pacing (in patients with dual chamber pacemakers) will have on the electrocardiogram including the QT Interval. The investigators are also interested in the differences caused by genes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00883610
The ClinicalTrials.gov registry entry for NCT00883610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00883610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00883610 about?
NCT00883610 is a clinical study titled "Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber Pacemakers". The purpose of this study is to learn what effect rapid atrial pacing (in patients with dual chamber pacemakers) will have on the electrocardiogram including the QT Interval. The investigators are also interested in the differences caused by genes.
What is the current status of trial NCT00883610?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2009-04. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00883610?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.